NGS-based RNA-Seq Market - Technology, Trends, Development, Key Manufacturers Analysis and Forecast to 2027
The Insight Partners added “NGS-based RNA-Seq Market Report 2019-2027” to its research database. The report is spread across 150 pages and supported by 14 company leaders.
(EMAILWIRE.COM, January 08, 2019 ) The Insight Partners published an Exclusive report on “NGS-based RNA-Seq Market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 150 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
The NGS-based RNA-seq market is expected to grow with a significant rate in the forecast period, owing to factors such as, increasing number of research activities, rapid growth in precision medicine, increasing number of RNA-seq grants, technological advancements in RNA-seq products and rapid growth in precision medicine. On other hand, the increasing applications of RNA-seq in research are likely to add more novel opportunities for the growth of the NGS-based RNA-seq market in the coming years.
Request a sample of this premium report at: http://bit.ly/2SHNc1w
Some of the key players influencing the market are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc., and Eurofins Scientific among others.
Global NGS-based RNA-Seq Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.
Next-generation sequencing used in the biological applications that allows identification of novel transcripts, alternative splicing events and post-transcriptional RNA editing evens. The method provides a better approach for gene expression profiling that include analysis of continuously changing cellular transcriptome. Moreover, the NGS-based RNA seg technique is used to determine exon/intron boundaries and verify or amend previously annotated and gene boundaries. The in situ sequencing of fixed tissue and single cell sequencing are the advantages of the NGS-based RNA-seq technique.
NGS-based RNA-Seq Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. NGS-based RNA-Seq Industry Insights
Chapter 4. NGS-based RNA-Seq Market, By Technology
Chapter 5. NGS-based RNA-Seq Market, By End-user
Chapter 6. NGS-based RNA-Seq Market, By Region
Chapter 7. Company Profiles
Request a discount on standard prices of this premium report at: http://bit.ly/2SGRdTV
The NGS-based RNA-seq market is expected to grow with a significant rate in the forecast period, owing to factors such as, increasing number of research activities, rapid growth in precision medicine, increasing number of RNA-seq grants, technological advancements in RNA-seq products and rapid growth in precision medicine. On other hand, the increasing applications of RNA-seq in research are likely to add more novel opportunities for the growth of the NGS-based RNA-seq market in the coming years.
Request a sample of this premium report at: http://bit.ly/2SHNc1w
Some of the key players influencing the market are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., Qaigen, F. Hoffmann-La Roche AG, Agilent Technologies, Inc., BGI, Oxford Nanopore Technologies, Perkinelmer, Inc., and Eurofins Scientific among others.
Global NGS-based RNA-Seq Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical white papers, paid databases etc. followed by primary research (interviews) with industry experts/KOLs to gain their insights and views on current scenarios and future scope of the market as well as validating the secondary information, further internal statistical model is used to estimate the market size and forecasts till 2027.
Next-generation sequencing used in the biological applications that allows identification of novel transcripts, alternative splicing events and post-transcriptional RNA editing evens. The method provides a better approach for gene expression profiling that include analysis of continuously changing cellular transcriptome. Moreover, the NGS-based RNA seg technique is used to determine exon/intron boundaries and verify or amend previously annotated and gene boundaries. The in situ sequencing of fixed tissue and single cell sequencing are the advantages of the NGS-based RNA-seq technique.
NGS-based RNA-Seq Market – Global Analysis to 2027 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.
Table of Content:
Chapter 1. Methodology
Chapter 2. Executive Summary
Chapter 3. NGS-based RNA-Seq Industry Insights
Chapter 4. NGS-based RNA-Seq Market, By Technology
Chapter 5. NGS-based RNA-Seq Market, By End-user
Chapter 6. NGS-based RNA-Seq Market, By Region
Chapter 7. Company Profiles
Request a discount on standard prices of this premium report at: http://bit.ly/2SGRdTV
Contact Information:
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Insight Partners
Sameer Joshi
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results